Introduction
Male factor is responsible for 30%-50% of all infertility, and genetic abnormalities are thought to account for 15%-30% of male factor infertility (1, 2) . Chromosomal aberrations play a major role in infertile men because findings have shown that sperm concentration is strongly correlated with the presence of chromosomal abnormalities (3, 4) . Since structural chromosomal aberrations are up to 10 times more common in infertile men than in fertile controls, karyotypes are important in the work-up of infertile men (5) . Structural chromosomal abnormalities in men can lead to abnormal sperm concentrations while leading to male infertility or increasing miscarriages (6, 7) . Reciprocal translocations are mainly structural chromosomal abnormalities, the carriers of which can be phenotypically normal but may experience reduced fertility and spontaneous abortions (8) . These effects are dependent on the specific chromosomes and breakpoints involved in the translocation (8, 9) . Some translocation breakpoints can interrupt an important gene structure, causing male infertility (10) .
Previous reports have indicated the involvement of chromosome 3 translocations in male infertility and recurrent pregnancy loss (11) (12) (13) . Sperm chromosome complements were studied in men heterozygous for the carriers of reciprocal chromosome 3 translocation. The frequency of spermatozoa carrying an abnormal chromosome constitution was found to be significantly higher than the frequency in control semen specimens (14) . However, Martin (15) reported that there was no evidence for an interchromosomal effect because the frequencies of numerical and structural abnormalities (unrelated to the translocation) were within the normal range of the control group. Additionally, the WD repeat-containing protein 10 gene (WDR 10) is located on chromosome 3q21 and highly expressed in testes (16) . The centrosomal protein 19-KD gene (CEP19), mapped on chromosome 3 at 3q29, may be associated with spermatogenic failure (17) .
The present study was performed to determine the correlation between the clinical characteristics of male infertility and the carriers of translocation breakpoints in chromosome 3. This paper also highlights the importance of genetic counseling for infertile patients.
Materials and methods

Study subjects
Between July 2010 and December 2015, 5235 men who were infertile or receiving counseling for infertility were recruited from among outpatients of the Center for Reproductive Medicine, First Hospital of Jilin University, Changchun, China. All patients underwent a thorough physical examination and a semen analysis and were required to complete a detailed questionnaire pertaining to their smoking, drinking, marital status, childbearing histories, spontaneous abortion status, medical history, and working conditions. Oligozoospermia was defined as per our previous definition (10) . The study protocol was approved by the Ethics Committee of First Hospital of Jilin University and written informed consent was obtained from all participants.
Cytogenetic analysis
All patients were subjected to a cytogenetic analysis. Peripheral blood (0.5 mL) was collected in sterile tubes containing 30 U/mL heparin. Lymphocytes were cultured in appropriate culture medium (Yishengjun; Guangzhou Baidi Biotech, Guangzhou, China) for 72 h and subsequently treated with 20 µg/mL colcemid for 1 h. G-banding of metaphase chromosomes and karyotype analysis were performed using our previously reported methods (18).
Analysis of translocation breakpoints reported
A search for translocations in chromosome 3 involved in male infertility was performed using PubMed, Google Scholar, and CNKI. The keywords were "chromosome / translocation / sperm" and "chromosome / translocation / abortion" for the PubMed search. Available papers were included from 1986 to 2017. We excluded those translocations involving chromosome 3 but with no reported breakpoint. The relationships of translocation breakpoints with male infertility and recurrent pregnancy loss were analyzed.
Results
A total of 82 translocation carriers were detected among 5235 male patients in this study. Of these carriers, 12 patients (12/82; 14.6%) were carriers of a chromosome 3 translocation. Two of these patients exhibited pregestational infertility (clinical manifestation: oligozoospermia), while the remaining ten patients exhibited gestational infertility (patients' partners were able to conceive but tended to miscarry). The results of a karyotype analysis of the 12 patients with chromosome 3 translocation are summarized in Table 1 .
Breakpoints at 3q12 and 3q21 were observed in three patients each. The breakpoint at 3p13 was related to pregestational infertility, while the breakpoints at 3p23, 3q10, 3q12, 3q21, 3q25, and 3q29 were related to gestational infertility (Table 2) .
From an analysis of the literature, 63 carriers of chromosome 3 translocations were reviewed. The breakpoints at 3q12 and 3q29 were the most common. All breakpoints were related to gestational infertility. The karyotypes of and breakpoints in chromosome 3 and their related clinical symptoms are summarized in Table 3 . (20) . Cytogenetic evaluation of men with abnormal sperm parameters reveals balanced translocations and abnormal karyotypes in up to 13% of them, significantly more frequently than in fertile controls (5) . Structural chromosomal abnormalities are associated with male factor infertility (7). In the previous literature, it was reported that the presence of translocations alters the process of spermatogenesis (21) . Chromosome 3 translocations are also often known to be involved in male infertility and recurrent pregnancy loss (11) (12) (13) 22) . Male factor infertility is divided into two types of reproductive failure: pregestational and gestational infertility (23) . In this study, chromosome 3 translocation was found to be associated with two cases of pregestational and 10 cases of gestational infertility. The breakpoint at 3p13 was related to pregestational infertility, while the breakpoints at 3p23, 3q10, 3q12, 3q21, 3q25, and 3q29 were related to gestational infertility. To investigate the relationship of the breakpoints at chromosome 3 and male infertility, an analysis of related literature published in recent years revealed a close association between breakpoints in chromosome 3 translocation carriers and male infertility and reproductive failure. Table 3 shows that all breakpoints were associated with recurrent pregnancy loss or recurrent miscarriages (11, 13, 24, 25) . These cases indicated that these breakpoints are not responsible for these conditions, suggesting that another breakpoint of translocation is responsible for pregestational infertility. Although WDR 10, located on chromosome 3q21, expressed in testes, and CEP19, mapped on chromosome 3q29, may be associated with spermatogenic failure (16, 17) , the details of their functions are unclear. Hence, carriers of chromosome 3 translocations should receive appropriate counseling to appraise them of suitable reproductive options. Patients with gestational infertility should be counseled regarding preimplantation genetic diagnosis or prenatal testing, as these patients are at an increased risk of recurrent fetal wastage (26) .
In conclusion, all breakpoints at chromosome 3 were correlated with gestational infertility. The breakpoints at 3q12 and 3q29 were the most common and were associated with gestational infertility. Carriers of chromosome 3 translocation should thus be counseled on the need for other chromosomal breakpoints and preimplantation genetic diagnosis or prenatal testing.
